Rui Zhao

7PUBLICATIONS

48CO-AUTHORS

AutoimmunityHaematological tumoursRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 19, 2026

Diffuse large B-cell lymphoma masquerading as multiple myeloma.

|Jun 17, 2026

Outcome of treatment with trametinib in adults with histiocytic neoplasms in the United Kingdom.

|Sep 12, 2024

Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy.

Jad Othman, Angela Hwang, Maximillian Brodermann

|Jul 08, 2024

CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK.

Priyanka Mehta, Victoria Campbell, Jamie Maddox

|Dec 21, 2023

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.

Ann Tivey, Rohan Shotton, Toby A Eyre

|Aug 30, 2023

Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.

Jad Othman, Ing S Tiong, Jenny O'Nions

Pageof 2

Frequent Collaborators

Anjum Khan

Justin Loke

Jenny O'Nions

Jamie Maddox

Tom Taylor

Priyanka Mehta

Jad Othman

Scott Marshall

Charles Craddock

Helen Parry

Frequent Collaborators

Anjum Khan

Justin Loke

Jenny O'Nions

Jamie Maddox